Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jun 1;101(22):8425-30.
doi: 10.1073/pnas.0400625101. Epub 2004 May 20.

Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice

Affiliations

Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice

Yun-Ping Wu et al. Proc Natl Acad Sci U S A. .

Abstract

Sandhoff disease is a prototypical lysosomal storage disorder in which a heritable deficiency of a lysosomal enzyme, beta-hexosaminidase, results in the storage of the enzyme's substrates in lysosomes. As with many of the other lysosomal storage diseases, neurodegeneration is a prominent feature. Although the cellular and molecular pathways that underlie the neurodegenerative process are not yet fully understood, macrophage/microglial-mediated inflammation has been suggested as one possible mechanism. We now show that the expanded macrophage/microglial population in the CNS of Sandhoff disease mice is compounded by the infiltration of cells from the periphery. Coincident with the cellular infiltration was an increased expression of macrophage-inflammatory protein 1alpha (MIP-1alpha), a leukocyte chemokine, in astrocytes. Deletion of MIP-1alpha expression resulted in a substantial decrease in infiltration and macrophage/microglial-associated pathology together with neuronal apoptosis in Sandhoff disease mice. These mice without MIP-1alpha showed improved neurologic status and a longer lifespan. The results indicate that the pathogenesis of Sandhoff disease involves an increase in MIP-1alpha that induces monocytes to infiltrate the CNS, expand the activated macrophage/microglial population, and trigger apoptosis of neurons, resulting in a rapid neurodegenerative course.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Localization and identification of HRP-labeled cells in Hexb-/- mice. In 3-month-old Hexb-/- mice, HRP-labeled cells were detected attached to the vascular wall in vessels in the spinal cord (a) and perivascular regions in the spinal cord (b). (c) In a 4-month-old Hexb-/- mouse, HRP-labeled cells were localized in the parenchyma of the thalamic nucleus. (d) An HRP-labeled cell in the thalamic nucleus of a 4-month-old Hexb-/- mouse was identified as Mac-1-positive (arrow). Arrowheads show Mac-1-positive cells. (Inset) A nickel-enhanced HRP-labeled cell. (Bars: 100 μmin a and b, 220 μmin c, and 60 μm in d.)
Fig. 2.
Fig. 2.
Expression of MIP-1α in Hexb+/+ and Hexb-/- mice. (a) The time course of relative MIP-1α mRNA expression levels in the cerebral cortex and spinal cord of Hexb-/- mice compared with age-matched Hexb+/+ mice. (bg) Immunofluorescent staining of the spinal cord with MIP-1α and GFAP antibodies. (bd) Control (Hexb+/+) sections. (eg) Hexb-/- sections. b and e show MIP-1α immunostaining. c and f show GFAP immunostaining. d and g show double immunostaining for MIP-1α and GFAP. Note that the MIP-1α and GFAP double-positive astrocytes (arrows in eg) are closely associated with vessels (*). (Bar: 60 μm.)
Fig. 3.
Fig. 3.
Preserved clinical condition of Sandhoff disease mice deficient for MIP-1α was clearly noted at 4 months of age compared with littermates. Hexb-/- mice with different MIP-1α genotypes are indicated.
Fig. 4.
Fig. 4.
Body weight, lifespan, and behavioral testing. (a) The body weight in Hexb-/-MIP-1α-/- and Hexb-/-MIP-1α+/- mice was higher at and after 15 weeks of age compared with Hexb-/-MIP-1α+/+ mice. The data are means from three to five mice for each genotype and data point. (b) Survival of the Hexb-/- mice with different MIP-1α backgrounds. Each group contained 10–15 mice. (c and d) Mean (±SEM) time to fall off the rotorod. Both Hexb-/-MIP-1α+/- and Hexb-/-MIP-1α-/- mice had significantly better (*) performances at all time points tested. The comparison was made only among the littermates. At all time points in c, n = 4 Hexb-/-MIP-1α+/+ mice and 4 Hexb-/-MIP-1α+/- mice. At all time points in d, n = 3 Hexb-/-MIP-1α+/+ mice and 3 Hexb-/-MIP-1α-/- mice. The righting reflex was tested at 17 (e) and 19 (f) weeks of age; n = 4 in each group and time point. Hexb-/-MIP-1α-/- mice had a significantly improved (*) righting reflex compared with other groups. All Hexb-/-MIP-1α+/+ mice were dead by 19 weeks old.
Fig. 5.
Fig. 5.
Lessened macrophage/microglia-associated pathology in Hexb-/-MIP-1α-/- mice compared with Hexb-/-MIP-1α+/+ mice. Hematoxylin/eosin and Mac-1 immunostaining show numerous foamy cells (a) and ameboid brain macrophages (c) in the thalamic nuclei of 4-month-old Hexb-/-MIP-1α+/+ mice. In the thalamic nuclei of 4-month-old Hexb-/-MIP-1α-/- mice foamy cells were rare (b) and ramified microglia were detected (d) instead of amoeboid brain macrophages. The arrows indicate foamy cells in the Hexb-/-MIP-1α+/+ mice, and the arrowheads indicate neurons with storage in both genotypes. (e and f) Reduction of HRP-labeled cells (arrow) in 4-month-old Hexb-/-MIP-1α-/- mice (f) compared with age-matched Hexb-/-MIP-1α+/+ mice (e). (g) Down-regulation of Mac-1α-subunit mRNA expression in the spinal cord of Hexb-/-MIP-1α-/- mice at 4 months old compared with age-matched Hexb-/-MIP-1α+/+ mice. (Bars: 20 μmin ad and 120 μmin e and f.)
Fig. 6.
Fig. 6.
Reduction of TUNEL-positive cells (arrows) in Hexb-/-MIP-1α-/- mice at 4 months old (b) compared with age-matched Hexb-/-MIP-1α+/+ mice (a). (d) TUNEL-positive cells were counted (*, P < 0.05). Data are means ± SEM (n = 3–5). (c) The TNF-α mRNA expression level was reduced in the spinal cord of Hexb-/-MIP-1α-/- mice compared with Hexb-/-MIP-1α+/+ mice at 4 months old. (Bar: 40 μm.)

Similar articles

Cited by

References

    1. Gravel, R. A., Kabak, M. M., Proia, R. L., Sandhoff, K., Suzuki, K. & Suzuki, K. (2001) in The Metabolic and Molecular Basis of Inherited Disease, eds. Scriver, C. R., Beaudet, A. L., Valle, D., Sly, W. S., Childs, B., Kinzler, K. W. & Vogelstein, B. (McGraw–Hill, New York), Vol. 3, pp. 3827-3876.
    1. Kolter, T., Proia, R. L. & Sandhoff, K. (2002) J. Biol. Chem. 277, 25859-25862. - PubMed
    1. Neufeld, E. F. (1991) Annu. Rev. Biochem. 60, 257-280. - PubMed
    1. Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D. (2001) in The Metabolic and Molecular Basis of Inherited Disease, eds. Scriver, C. R., Beaudet, A. L., Valle, D., Sly, W. S., Childs, B., Kinzler, K. W. & Vogelstein, B. (McGraw-Hill, New York), pp. 3371-3896.
    1. Sly, W. S. & Vogler, C. (2002) Proc. Natl. Acad. Sci. USA 99, 5760-5762. - PMC - PubMed

MeSH terms